Sign in

CIK 0001285819

  • Non-accelerated filer
  • Smaller reporting company

OMEROS CORP

Sign in to watch
Ticker
OMER
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911663741
Phone
+1 206-676-5000
Business address
201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale Director sold 3,000 shares at $10.21 ($30,642)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Chairman, CEO & President sold 306,124 shares at an average $10.66 ($3,263,485)
  7. 4 Open-market sale Chairman, CEO & President sold 306,120 shares at an average $11.58 ($3,546,135)
  8. 4 Exercise or conversion VP Patent and General Counsel acquired 3,004 shares (option exercise)
  9. 4 Open-market sale VP Patent and General Counsel sold 16,000 shares at $10.91 ($174,578)
  10. 4 Open-market sale VP Patent and General Counsel sold 15,900 shares at $11.56 ($183,826)
  11. 4 Open-market sale Director sold 3,000 shares at $11.52 ($34,557)
  12. 4 Open-market sale VP Patent and General Counsel sold 15,900 shares at $11.50 ($182,804)
  13. 4 Open-market sale VP Patent and General Counsel sold 15,900 shares at $11.42 ($181,503)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale VP Patent and General Counsel sold 15,900 shares at $9.94 ($158,057)

Page 9 of 15 · 295 filings